One of the leading causes of death among women and men in the United States is that of coronary heart disease. Most often, the condition is treated through a number of lifestyle changes, medications and surgeries. While this is the case, there are some individuals whom have now turned to oral chelation therapy which uses ethylene diamine tetra-acetic acid or EDTA, a controversial though complementary treatment.
The compound used in this therapy has not been reviewed or rated by the U. S. Food and Drug Administration. Regardless, there were over 110,000 Americans whom had previously opted for the treatment prior to a 2007 study. Ultimately, the therapy promotes a chemical process which works to bind molecules to metals and minerals.
The therapy was originally used to eliminate toxic and excess metals from the body. EDTA has had some uses in Western medicine, mostly with regards to iron overload and lead poisoning. Whereas, when used to treat heart disease, a health care provider generally administers a series of injections into the veins over time which include disodium EDTA, a man made amino acid. In most cases, the treatment requires individuals to complete thirty or more infusions which can often take several hours per visit, most often on a weekly basis.
To help determine whether this therapy might be helpful in treating heart attack victims, two organizations supported a trial. The purpose of the trial, to determine the success rate of the therapy on individuals with a previous history of heart attacks and heart disease. The results showed that the infusions were successful in dropping the number of occurrences, though only in people whom were also diabetic.
During the study, individuals with diabetes made up approximately one third of participants. During the trial, diabetics showed a forty one percent reduction in cardiovascular events and a forty percent risk of death from heart disease, stroke or non-fatal heart attacks. In addition, fifty two percent experienced a reduction in repetitive heart attacks and a forty three percent reduction in death from other causes. Whereas, individuals whom did not have diabetes did not experience any significant benefits from the disodium EDTA infusions.
The trial also included individuals whom were taking high dose vitamins and minerals while receiving chelation therapy. In most cases, the combination provided the highest drops in heart attack risks among participants versus others whom were only provided placebos.
During the trial, sixteen percent of individuals receiving the chelation therapy and fifteen percent receiving placebos ceased the injections due to adverse reactions. In four cases, the events were serious. Whereas, there was one death in each the chelation therapy group and the placebo group. To date, the main side of effect related to EDTA remains a burning sensation when the solution is placed in the vein.
As with almost all medical studies, more research is needed before a final determination as to the success of the therapy can be made. For, these reports are from the first study ever conducted. As such, the information provided through the study does not provide enough detail to support the infusions as being a safe or effective treatment for heart attack victims.
The compound used in this therapy has not been reviewed or rated by the U. S. Food and Drug Administration. Regardless, there were over 110,000 Americans whom had previously opted for the treatment prior to a 2007 study. Ultimately, the therapy promotes a chemical process which works to bind molecules to metals and minerals.
The therapy was originally used to eliminate toxic and excess metals from the body. EDTA has had some uses in Western medicine, mostly with regards to iron overload and lead poisoning. Whereas, when used to treat heart disease, a health care provider generally administers a series of injections into the veins over time which include disodium EDTA, a man made amino acid. In most cases, the treatment requires individuals to complete thirty or more infusions which can often take several hours per visit, most often on a weekly basis.
To help determine whether this therapy might be helpful in treating heart attack victims, two organizations supported a trial. The purpose of the trial, to determine the success rate of the therapy on individuals with a previous history of heart attacks and heart disease. The results showed that the infusions were successful in dropping the number of occurrences, though only in people whom were also diabetic.
During the study, individuals with diabetes made up approximately one third of participants. During the trial, diabetics showed a forty one percent reduction in cardiovascular events and a forty percent risk of death from heart disease, stroke or non-fatal heart attacks. In addition, fifty two percent experienced a reduction in repetitive heart attacks and a forty three percent reduction in death from other causes. Whereas, individuals whom did not have diabetes did not experience any significant benefits from the disodium EDTA infusions.
The trial also included individuals whom were taking high dose vitamins and minerals while receiving chelation therapy. In most cases, the combination provided the highest drops in heart attack risks among participants versus others whom were only provided placebos.
During the trial, sixteen percent of individuals receiving the chelation therapy and fifteen percent receiving placebos ceased the injections due to adverse reactions. In four cases, the events were serious. Whereas, there was one death in each the chelation therapy group and the placebo group. To date, the main side of effect related to EDTA remains a burning sensation when the solution is placed in the vein.
As with almost all medical studies, more research is needed before a final determination as to the success of the therapy can be made. For, these reports are from the first study ever conducted. As such, the information provided through the study does not provide enough detail to support the infusions as being a safe or effective treatment for heart attack victims.
About the Author:
When you are looking for information about oral chelation, come to our web pages today. More details are available at http://www.heartdrop.com now.
This article collected, selected and written by: Author Van Hoc
Niche blogs are sometimes referred to as splogs, but this is a misnomer. Even though the desired end result for the niche blogger is to make money...
Get Free Email Updates to your Inbox!
Post a Comment